*Unresectable is defined as cancer that cannot be removed by surgery. Metastatic is defined as cancer that has spread to other parts of the body.
HER2, human epidermal growth factor receptor 2.

What is ENHERTU?

ENHERTU (en-HER-too) is a prescription medicine used to treat adults who have non-small cell lung cancer (NSCLC) that has a certain mutation in the HER2 gene and cannot be removed by surgery or has spread to other parts of your body (metastatic), and who have received a prior treatment. Your healthcare provider will perform a test to make sure ENHERTU is right for you.

ENHERTU was FDA approved for this use based on a clinical study that measured how many patients responded and how long they responded.
ENHERTU is still being studied to confirm these results.

It is not known if ENHERTU is safe and effective in children.

What is the most important information I should know about ENHERTU?

ENHERTU can cause serious side effects, including:

  • Lung problems that may be severe, life-threatening or that may lead to death. If you develop lung problems your healthcare provider may treat you with corticosteroid medicines. Tell your healthcare provider right away if you get any of the following signs and symptoms:

Please see full Prescribing Information, including Boxed WARNINGS, and Medication Guide.

Learn about ENHERTU4U

Potential side effects of treatment with ENHERTU

Learn about ENHERTU4U

Treatment access and downloadable resources

HER2, human epidermal growth factor receptor 2; HR, hormone receptor; mBC, metastatic breast cancer.